201 related articles for article (PubMed ID: 21929744)
1. Impact of type 2 diabetes and the metabolic syndrome on myocardial structure and microvasculature of men with coronary artery disease.
Campbell DJ; Somaratne JB; Jenkins AJ; Prior DL; Yii M; Kenny JF; Newcomb AE; Schalkwijk CG; Black MJ; Kelly DJ
Cardiovasc Diabetol; 2011 Sep; 10():80. PubMed ID: 21929744
[TBL] [Abstract][Full Text] [Related]
2. Diastolic dysfunction of aging is independent of myocardial structure but associated with plasma advanced glycation end-product levels.
Campbell DJ; Somaratne JB; Jenkins AJ; Prior DL; Yii M; Kenny JF; Newcomb AE; Schalkwijk CG; Black MJ; Kelly DJ
PLoS One; 2012; 7(11):e49813. PubMed ID: 23189164
[TBL] [Abstract][Full Text] [Related]
3. Differences in myocardial structure and coronary microvasculature between men and women with coronary artery disease.
Campbell DJ; Somaratne JB; Jenkins AJ; Prior DL; Yii M; Kenny JF; Newcomb AE; Kelly DJ; Black MJ
Hypertension; 2011 Feb; 57(2):186-92. PubMed ID: 21135353
[TBL] [Abstract][Full Text] [Related]
4. Obesity is associated with lower coronary microvascular density.
Campbell DJ; Somaratne JB; Prior DL; Yii M; Kenny JF; Newcomb AE; Kelly DJ; Black MJ
PLoS One; 2013; 8(11):e81798. PubMed ID: 24312359
[TBL] [Abstract][Full Text] [Related]
5. Coronary microvascular function is independently associated with left ventricular filling pressure in patients with type 2 diabetes mellitus.
Kawata T; Daimon M; Miyazaki S; Ichikawa R; Maruyama M; Chiang SJ; Ito C; Sato F; Watada H; Daida H
Cardiovasc Diabetol; 2015 Aug; 14():98. PubMed ID: 26242308
[TBL] [Abstract][Full Text] [Related]
6. Reduced microvascular density in non-ischemic myocardium of patients with recent non-ST-segment-elevation myocardial infarction.
Campbell DJ; Somaratne JB; Jenkins AJ; Prior DL; Yii M; Kenny JF; Newcomb AE; Kelly DJ; Black MJ
Int J Cardiol; 2013 Aug; 167(3):1027-37. PubMed ID: 22459379
[TBL] [Abstract][Full Text] [Related]
7. Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction.
Mohammed SF; Hussain S; Mirzoyev SA; Edwards WD; Maleszewski JJ; Redfield MM
Circulation; 2015 Feb; 131(6):550-9. PubMed ID: 25552356
[TBL] [Abstract][Full Text] [Related]
8. Effects of type 2 diabetes mellitus on coronary microvascular function and myocardial perfusion in patients without obstructive coronary artery disease.
Marciano C; Galderisi M; Gargiulo P; Acampa W; D'Amore C; Esposito R; Capasso E; Savarese G; Casaretti L; Lo Iudice F; Esposito G; Rengo G; Leosco D; Cuocolo A; Perrone-Filardi P
Eur J Nucl Med Mol Imaging; 2012 Jul; 39(7):1199-206. PubMed ID: 22526959
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative assessment of left-ventricular diastolic function by two-dimensional speckle tracking echocardiography: relationship between pulmonary capillary wedge pressure and peak longitudinal strain rate during isovolumetric relaxation in patients undergoing coronary artery bypass graft surgery.
Ebrahimi F; Kohanchi D; Gharedaghi MH; Petrossian V
J Cardiothorac Vasc Anesth; 2019 Apr; 33(4):1014-1021. PubMed ID: 30072270
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor-gamma activation attenuates cardiac fibrosis in type 2 diabetic rats: the effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth factor.
Ihm SH; Chang K; Kim HY; Baek SH; Youn HJ; Seung KB; Kim JH
Basic Res Cardiol; 2010 May; 105(3):399-407. PubMed ID: 19902320
[TBL] [Abstract][Full Text] [Related]
11. Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension.
van Heerebeek L; Hamdani N; Handoko ML; Falcao-Pires I; Musters RJ; Kupreishvili K; Ijsselmuiden AJ; Schalkwijk CG; Bronzwaer JG; Diamant M; Borbély A; van der Velden J; Stienen GJ; Laarman GJ; Niessen HW; Paulus WJ
Circulation; 2008 Jan; 117(1):43-51. PubMed ID: 18071071
[TBL] [Abstract][Full Text] [Related]
12. [The absence of characteristics lesions in the microcirculation of non-insulin-dependent diabetic patients].
García Aguilar J; Lerman Garber I; Aranda Frausto A; Posadas Romero C
Arch Inst Cardiol Mex; 1993; 63(3):209-17. PubMed ID: 8347050
[TBL] [Abstract][Full Text] [Related]
13. Multiple common comorbidities produce left ventricular diastolic dysfunction associated with coronary microvascular dysfunction, oxidative stress, and myocardial stiffening.
Sorop O; Heinonen I; van Kranenburg M; van de Wouw J; de Beer VJ; Nguyen ITN; Octavia Y; van Duin RWB; Stam K; van Geuns RJ; Wielopolski PA; Krestin GP; van den Meiracker AH; Verjans R; van Bilsen M; Danser AHJ; Paulus WJ; Cheng C; Linke WA; Joles JA; Verhaar MC; van der Velden J; Merkus D; Duncker DJ
Cardiovasc Res; 2018 Jun; 114(7):954-964. PubMed ID: 29432575
[TBL] [Abstract][Full Text] [Related]
14. Which factor is the most effective one in metabolic Sydrome on the outcomes after coronary artery bypass graft surgery? A cohort study of 5 Years.
Wang L; Qian X; Wang M; Tang X; Ao H
J Cardiothorac Surg; 2018 Jan; 13(1):1. PubMed ID: 29301583
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Syndrome Is Associated With Impaired Diastolic Function Independently of MRI-Derived Myocardial Extracellular Volume: The MESA Study.
Ladeiras-Lopes R; Moreira HT; Bettencourt N; Fontes-Carvalho R; Sampaio F; Ambale-Venkatesh B; Wu C; Liu K; Bertoni AG; Ouyang P; Bluemke DA; Lima JA
Diabetes; 2018 May; 67(5):1007-1012. PubMed ID: 29444891
[TBL] [Abstract][Full Text] [Related]
16. Left ventricular pressure-volume measurements and myocardial gene expression profile in type 2 diabetic Goto-Kakizaki rats.
Korkmaz-Icöz S; Lehner A; Li S; Vater A; Radovits T; Brune M; Ruppert M; Sun X; Brlecic P; Zorn M; Karck M; Szabó G
Am J Physiol Heart Circ Physiol; 2016 Oct; 311(4):H958-H971. PubMed ID: 27521423
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin attenuates cardiac dysfunction by increasing myocardial angiogenesis and inhibiting interstitial fibrosis in diabetic rats.
Lu J; Yao YY; Dai QM; Ma GS; Zhang SF; Cao L; Ren LQ; Liu NF
Cardiovasc Diabetol; 2012 Sep; 11():105. PubMed ID: 22954171
[TBL] [Abstract][Full Text] [Related]
18. Sitagliptin alleviated myocardial remodeling of the left ventricle and improved cardiac diastolic dysfunction in diabetic rats.
Liu YS; Huang ZW; Wang L; Liu XX; Wang YM; Zhang Y; Zhang M
J Pharmacol Sci; 2015 Mar; 127(3):260-74. PubMed ID: 25837922
[TBL] [Abstract][Full Text] [Related]
19. HMGCoA reductase inhibition reverses myocardial fibrosis and diastolic dysfunction through AMP-activated protein kinase activation in a mouse model of metabolic syndrome.
Hermida N; Markl A; Hamelet J; Van Assche T; Vanderper A; Herijgers P; van Bilsen M; Hilfiker-Kleiner D; Noppe G; Beauloye C; Horman S; Balligand JL
Cardiovasc Res; 2013 Jul; 99(1):44-54. PubMed ID: 23542580
[TBL] [Abstract][Full Text] [Related]
20. Impaired left ventricular function and myocardial blood flow reserve in patients with long-term type 1 diabetes and no significant coronary artery disease: associations with protein glycation.
Sveen KA; Nerdrum T; Hanssen KF; Brekke M; Torjesen PA; Strauch CM; Sell DR; Monnier VM; Dahl-Jørgensen K; Steine K
Diab Vasc Dis Res; 2014 Mar; 11(2):84-91. PubMed ID: 24443481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
